Remove Diagnose Remove Diagnosis Remove Family Remove Screening
article thumbnail

Decisional Regret Two-Year after Diagnosis with Low-risk Prostate Cancer in a Population-based Sample [Cancer research (not screening)]

Annals of Family Medicine

Context: Men newly diagnosed with low-risk prostate cancer (LPC) have multiple treatment options available, each with potential effects on quality of life (QOL). Objective: To assess decisional regret (DR) and QOL changes by treatment choice (surgery, radiation or active surveillance) two years after diagnosis in a cohort of men with LPC.

Diagnosis 130
article thumbnail

Assessment of Project ECHO(R) Opioid Use Disorder Sessions for Primary Care Teams [Education and training]

Annals of Family Medicine

4 expert faculty members developed session curriculum: screening and diagnosis, using behavioral health/counseling, addressing harm reduction, among others. Participants were more confident in screening and diagnosing, harm reduction, and motivational interviewing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI Model Can Aid Physicians in Skin Cancer Diagnoses

Physician's Weekly

TUESDAY, June 17, 2025 (HealthDay News) — The PanDerm artificial intelligence (AI) model improves skin cancer diagnosis when used by doctors, according to a research article published online June 6 in Nature Medicine. The post AI Model Can Aid Physicians in Skin Cancer Diagnoses first appeared on Physician's Weekly.

article thumbnail

Rare Diseases: Pathways to accelerating diagnoses 

Myriad Genetics

Many of us have seen stories in the news about American families on diagnostic odysseys for their children with rare diseases. Which one of those 17 doctors ultimately was able to pull together the pieces of Alex’s health picture and suggest a diagnosis? None of them. It was the AI program ChatGPT.

article thumbnail

A New Outlook: How Carrier Screening Shaped One Family’s Future

Myriad Genetics

When Ashley Pantier and her husband decided to start a family, they were young, healthy, and filled with a sense of joyful optimism. We went through the pediatrician, the physical therapist, and none of those people brought up carrier screening. Ashley’s journey to a diagnosis for Christopher probably felt like forever to their family.

article thumbnail

AMPLIFY™ Technology Enhances Prenatal Screening for 22q11.2 Microdeletion

Myriad Genetics

Typically, the way to diagnose 22q prenatally is through chorionic villus sampling or an amniocentesis. Less invasive options like prenatal cell-free DNA (cfDNA) screens can also be used to help identify the microdeletion. Thus, the value of using cfDNA screens for 22q has been marginal. Such is the case with the 22q11.2

article thumbnail

Screening for Dementia: A Podcast with Anna Chodos, Joseph Gaugler and Soo Borson

GeriPal

Summary Transcript Summary The US Preventive Services Task Force (USPSTF) concluded back in 2000 that there is insufficient evidence to recommend for or against routine screening for dementia in older adults. If so, how do we screen and who do we screen? What should we use to screen individuals? Cognitive screening.

Screening 119